BridgeBio Oncology Therapeutics BBOT
NASDAQ BBOT
$3.94 -0.16 (-3.90%)
At close: Oct 1, 2026 · 4:00 PM EDT

BridgeBio Oncology Therapeutics (BBOT) Accumulated Expenses (2023 - 2025)

Updated

BridgeBio Oncology Therapeutics' Accumulated Expenses was $1.78 million in Q1 2025, compared with $23,333 a year earlier.

Analysis

BridgeBio Oncology Therapeutics (BBOT) Accumulated Expenses (2023 - 2025) Analysis & Trends

At the end of FY2024, Accumulated Expenses at BridgeBio Oncology Therapeutics came in at $119,706, up 698.0% from FY2023.

  • In earlier years, Accumulated Expenses was $15,000 in FY2023.
  • Per Business Quant data, BBOT's Accumulated Expenses in the three quarters before Q1 2025 was $119,706 (Q4 2024), $126,690 (Q3 2024) and $79,141 (Q2 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 BridgeBio Oncology Therapeutics 328.47 Mn -1.04 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 1.78 Mn
Dec 31, 2024 119,706.00
Sep 30, 2024 126,690.00
Jun 30, 2024 79,141.00
Mar 31, 2024 23,333.00
Dec 31, 2023 15,000.00
API Access

BridgeBio Oncology Therapeutics Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=BBOT&period=max&api_key=YOUR_API_KEY